| |
| Trade Name | VISX STAR EXCIMER LASER SYSTEM |
| Classification Name | excimer laser system |
| Generic Name | excimer laser for ophthalmic use |
| Applicant | VISX, INCORPORATED |
| PMA Number | P930016 |
| Supplement Number | S012 |
| Date Received | 07/14/2000 |
| Decision Date | 04/27/2001 |
| Product Code | |
| Docket Number | 01M-0305 |
| Notice Date | 07/23/2001 |
| Advisory Committee |
Ophthalmic |
| Supplement Type | panel track |
| Supplement Reason | labeling change - indications |
| Expedited Review Granted? | Yes |
| Combination Product |
No
|
| Information About: |
Labeling, Approval Order, Summary of Safety and Effectiveness |
Approval Order Statement Approval for the visx star s2 and s3 excimer laser systems. The devices are indicated for laser in-situ keratomileusis (lasik) treatments: 1) in patients with documented evidence of a change in manifest refraction of no more than 0. 5 d (in both cylinder and sphere components) for at least one year prior to the date of pre-operative examination; and 2) in patients 21 years of age or older in treatments for the reduction of elimination of naturally occurring hyperopia between +05 and +5. 0 d sphere at the spectacle plane with or without refractive astigmatism up to +3. 0 d, with a maximum manifest refraction spherical equivalent (mrse) of +6. 0 d. |
| Approval Order |
Approval Order
|